Ann Neuer

October 23, 2018 | There is a very real onslaught of technologies overwhelming investigative sites, which raises concerns as to whether site staffers have the expertise and comfort to work with all or even some of these tools. To understand what’s involved in becoming proficient in the expanding cadre of tools, and how they impact quality and conduct of clinical trials, the Association of Clinical Research Professionals (ACRP) is diving head first into this subject.

New research from Yale and the University of California San Francisco reveals that few medical devices are analyzed for the impact of gender on safety and effectiveness. It is widely known that women, as well as elderly and minority populations, have long been underrepresented in clinical trials for drugs and biologics, but as reported in JAMA Internal Medicine, a new study found a similar pattern when it comes to evaluating medical devices.

Note: To send this article to a friend, your Facebook chat must be turned on. Rhonda Schechter, an attorney specializing in Health Law, will speak to the Blue Ash Northeast Democratic Club (BANDC) at 7 p.m. Tuesday, March 21, at the Blue Ash Recreation Center at 4433 Cooper Road. Schechter, a senior associate at Frost Brown Todd, will discuss the very real impact on Ohioans, their doctors, and hospitals of the possible repeal of the Affordable Care Act.